Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIPH-TB Protocol vs Standard RIPE in Newly Diagnosed Pulmonary Tuberculosis
NCT07467252Phase 2Not yet recruiting
- Sponsor
- Ministry of Health
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine, pyrazinamide in pulmonary tuberculosis (TB), sponsored by Ministry of Health. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
hydroxychloroquinepyrazinamide
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT07467252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07467252.